Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| OPLØST EFTER FRIVILLIG LIKVIDATION | 29.04.2019 | 29.04.2019 |
| UNDER FRIVILLIG LIKVIDATION | 20.08.2018 | 28.04.2019 |
| NORMAL | 29.11.2017 | 19.08.2018 |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| Forskning og eksperimentel udvikling indenfor bioteknologi (721100) | 29.11.2017 | 29.04.2019 |
| Virksomheden har ikke ændret Branche i sin
levetid. |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| false | 29.11.2017 | 29.04.2019 |
| Virksomheden har ikke ændret Revision i sin
levetid. |
Ingen nuværende registrering.
Ingen nuværende registrering.
Ingen nuværende registrering.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Historik | Start | Stop |
|---|
| IGM Biosciences A/S | 29.11.2017 | 29.04.2019 |
| Virksomheden har ikke ændret Navne i sin
levetid. |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| Virksomheden tegnes af en likvidator | 20.08.2018 | 29.04.2019 |
| Selskabet tegnes af formanden for bestyrelsen i forening med en direktør, eller af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse | 29.11.2017 | 19.08.2018 |
Ingen nuværende registrering.
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion:In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at December 31, 2017 and of the results of the Company’s operations as well as the cash flows for the financial year November 29 to December 31, 2017 in accordance with International Financial Reporting Standards as adopted by the EU and further requirements in the Danish Financial Statements Act. We have audited the Financial Statements of IGM Biosciences A/S for the financial year November 29 - December 31, 2017, which comprise income statement, balance sheet, statement of changes in equity, cash flow statement and notes, including a summary of significant accounting policies as well as statement of comprehensive income (“financial statements”).
Udtalelse om ledelsesberetningen:Management is responsible for Management’s review. Our opinion on the financial statements døs not cover Management’s review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read Management’s review and, in doing so, consider whether Management’s review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s review provides the information required under the Danish Financials Statements Act. Based on the work we have performed, in our view, Management’s review is in accordance with the Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement in Management’s review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration